ausiopharma.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Ausio Pharmaceuticals, |
| Description | Home About Ausio Lead Compound & Development AUS-131 and Patents Preclinical Studies Clinical Studies Business & Partnering Strategy Business & Partnering |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 206.188.192.78 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
ausiopharma.com Valuation
|
US$3,399,004
Last updated: 2023-05-18 12:16:43
ausiopharma.com has Semrush global rank of 3,113,943. ausiopharma.com has an estimated worth of US$ 3,399,004, based on its estimated Ads revenue. ausiopharma.com receives approximately 392,193 unique visitors each day. Its web server is located in United States, with IP address 206.188.192.78. According to SiteAdvisor, ausiopharma.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$3,399,004 |
| Daily Ads Revenue | US$3,138 |
| Monthly Ads Revenue | US$94,127 |
| Yearly Ads Revenue | US$1,129,515 |
| Daily Unique Visitors | 26,147 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| ausiopharma.com. | A | 7199 | IP: 206.188.192.78 |
| ausiopharma.com. | NS | 7200 | NS Record: ns43.worldnic.com. |
| ausiopharma.com. | NS | 7200 | NS Record: ns44.worldnic.com. |
| ausiopharma.com. | MX | 7200 | MX Record: 10 mx001.netsol.xion.oxcs.net. |
| ausiopharma.com. | MX | 7200 | MX Record: 10 mx002.netsol.xion.oxcs.net. |
| ausiopharma.com. | TXT | 900 | TXT Record: MS=ms94875416 |
| ausiopharma.com. | TXT | 7200 | TXT Record: v=spf1 include:spf.registeredsite.com include:spf.cloudus.rs.oxcs.net ~all |
HtmlToTextCheckTime:2023-05-18 12:16:43
| Home About Ausio Lead Compound & Development AUS-131 and Patents Preclinical Studies Clinical Studies Business & Partnering Strategy Business & Partnering Strategy visit Finpecia Ausio Pharmaceuticals, LLC, is a clinical-stage biotechnology development company focused on the advancement of safe and effective medicines. Ausio’s lead product is AUS-131, a first-in-class, nonsteroidal, nonhormonal estrogen receptor β (ERβ) agonist. Ausio has successfully completed two Phase 1 trials, a Phase 2a study for menopausal symptoms and a Phase 2a for benign prostatic hyperplasia (BPH). Ausio is currently conduction clinical studies for Alzheimer’s disease patients and for women with triple negative breast cancer. . The company has garnered a strong patent position for AUS-131. Ausio has developed AUS-131 as a pharmaceutical agent through a rigorous drug development process, as required by the US Food and Drug Administration (FDA). Ausio’s strategic goal is to collaborate with partners for |
HTTP Headers
HTTP/1.1 200 OK Server: openresty/1.19.9.1 Date: Fri, 17 Jun 2022 08:20:40 GMT Content-Type: text/html Content-Length: 4223 Connection: keep-alive Vary: Accept-Encoding Last-Modified: Mon, 26 Mar 2018 18:52:50 GMT ETag: "107f-5685547dca0c9" X-Webcom-Cache-Status: BYPASS Accept-Ranges: bytes |
ausiopharma.com Whois Information
Domain Name: AUSIOPHARMA.COM Registry Domain ID: 612491429_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.networksolutions.com Registrar URL: http://networksolutions.com Updated Date: 2017-07-30T16:32:42Z Creation Date: 2006-09-29T02:41:10Z Registry Expiry Date: 2022-09-29T02:41:10Z Registrar: Network Solutions, LLC Registrar IANA ID: 2 Registrar Abuse Contact Email: abuse@web.com Registrar Abuse Contact Phone: +1.8003337680 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS43.WORLDNIC.COM Name Server: NS44.WORLDNIC.COM DNSSEC: unsigned >>> Last update of whois database: 2022-06-17T08:18:30Z <<< |